Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Schistosoma mansoni | hypothetical protein | 0.02 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.02 | 1 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0115 | 0.5349 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0103 | 0.4726 | 0.8743 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Brugia malayi | Thioredoxin reductase | 0.0045 | 0.1588 | 0.2788 |
Brugia malayi | glutathione reductase | 0.0045 | 0.1588 | 0.2788 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0388 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0103 | 0.4692 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0103 | 0.4692 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0045 | 0.1588 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0045 | 0.1588 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0103 | 0.4726 | 0.8743 |
Entamoeba histolytica | hypothetical protein | 0.0075 | 0.3194 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0075 | 0.3194 | 0.2919 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0045 | 0.1588 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0103 | 0.4692 | 0.4478 |
Leishmania major | trypanothione reductase | 0.0045 | 0.1588 | 1 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.0388 | 0.2443 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0103 | 0.4726 | 0.8743 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Brugia malayi | hypothetical protein | 0.0075 | 0.3194 | 0.652 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0103 | 0.4726 | 0.8743 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0115 | 0.5349 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0045 | 0.1588 | 0.2418 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0103 | 0.4692 | 0.4478 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0388 | 0.2443 |
Entamoeba histolytica | hypothetical protein | 0.0075 | 0.3194 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0075 | 0.3194 | 0.2919 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0388 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.02 | 1 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0046 | 0.162 | 0.1282 |
Entamoeba histolytica | hypothetical protein | 0.0075 | 0.3194 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0045 | 0.1588 | 0.2788 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0103 | 0.4692 | 0.4478 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0115 | 0.5349 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0103 | 0.4726 | 0.8743 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.0388 | 0.2443 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0103 | 0.4692 | 0.4478 |
Plasmodium vivax | glutathione reductase, putative | 0.0045 | 0.1588 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0103 | 0.4692 | 0.4478 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0388 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0388 | 0.2443 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0046 | 0.162 | 0.1282 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0103 | 0.4692 | 0.4478 |
Plasmodium falciparum | glutathione reductase | 0.0045 | 0.1588 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0045 | 0.1588 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0388 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0388 | 0.2443 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0103 | 0.4692 | 0.4478 |
Schistosoma mansoni | hypothetical protein | 0.0075 | 0.3194 | 0.2919 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0075 | 0.3194 | 0.2919 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0388 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0045 | 0.1588 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0115 | 0.5349 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0103 | 0.4726 | 0.8743 |
Entamoeba histolytica | hypothetical protein | 0.0075 | 0.3194 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0045 | 0.1588 | 0.2788 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0388 | 0.2443 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.